Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hui-zhou Li"'
Autor:
Hui-Zhou Li, Qing-Qing Liu, De-Hua Chang, Shu-Xian Li, Long-Tao Yang, Peng Zhou, Jiang-Bei Deng, Chang-Hao Huang, Yu-Dong Xiao
Publikováno v:
Biomedicines, Vol 11, Iss 8, p 2196 (2023)
To improve the survival of patients with hepatocellular carcinoma (HCC), new biomarkers and therapeutic targets are urgently needed. In this study, the GEO and TCGA dataset were used to explore the differential co-expressed genes and their prognostic
Externí odkaz:
https://doaj.org/article/60c0ee715fbd43b28250583b2cbc2bc9
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background To compare the efficacy and safety between conventional transarterial chemoembolization (cTACE) and drug-eluting beads TACE (DEB-TACE) in patients with infiltrative hepatocellular carcinoma (iHCC). Methods A total of 89 iHCC patie
Externí odkaz:
https://doaj.org/article/d32b2fa75bc24fddaf32c8587ade0915
Publikováno v:
Jichu yixue yu linchuang, Vol 40, Iss 1, Pp 83-91 (2020)
Objective To explore the role and molecular mechanism of Neferine (Nef) on PC12 cells injury induced by Aβ1-42. Methods PC12 cells were divided into control group, model group(4 μg/mL Aβ1-42 cultured for 24 h) and low, medium and high-dose neferin
Externí odkaz:
https://doaj.org/article/2917eb9af2084822aeb030955fbecef7
Publikováno v:
Journal of Biochemical & Molecular Toxicology; Mar2024, Vol. 38 Issue 3, p1-12, 12p
Publikováno v:
Drug Design, Development and Therapy. 17:1125-1138
Xin Liu,1,* Miao Tang,2,* Tian-Yi He,1 Shuang Zhao,1 Hui-Zhou Li,1 Zhao Li,1 Yue-Xian Guo,3 Xiu-Li Wang1 1Department of Anesthesiology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050051, Peopleâs Republic of Chi
Publikováno v:
Journal of Hepatocellular Carcinoma
Hui-Zhou Li,1 Jie Tan,1 Tian Tang,2 Tian-Zhi An,3 Jun-Xiang Li,4 Yu-Dong Xiao1 1Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, 410011, Peopleâs Republic of China; 2Department of Interventional Radiolo
Autor:
Hui-Zhou Li, Qing-Qing Liu, De-Hua Chang, Chang-Hao Huang, Shu-Xian Li, Long-Tao Yang, Yu-Dong Xiao
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Background To compare the efficacy and safety between conventional transarterial chemoembolization (cTACE) and drug-eluting beads TACE (DEB-TACE) in patients with infiltrative hepatocellular carcinoma (iHCC). Methods A total of 89 iHCC patients who w